ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Axis Auto Finance Inc

Axis Auto Finance Inc (AXIS)

0.01
0.00
(0.00%)
Closed October 03 4:12PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.01
Bid
0.01
Ask
0.015
Volume
-
0.00 Day's Range 0.00
0.01 52 Week Range 0.115
Market Cap
Previous Close
0.01
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
34,696
Shares Outstanding
120,841,000
Dividend Yield
-
PE Ratio
-0.05
Earnings Per Share (EPS)
-0.22
Revenue
-
Net Profit
-26.18M

About Axis Auto Finance Inc

Sector
Personal Credit Institutions
Industry
Business Services, Nec
Headquarters
Mississauga, Ontario, Can
Founded
2016
Axis Auto Finance Inc is listed in the Personal Credit Institutions sector of the Toronto Stock Exchange with ticker AXIS. The last closing price for Axis Auto Finance was $0.01. Over the last year, Axis Auto Finance shares have traded in a share price range of $ 0.01 to $ 0.115.

Axis Auto Finance currently has 120,841,000 shares outstanding. The market capitalization of Axis Auto Finance is $1.21 million. Axis Auto Finance has a price to earnings ratio (PE ratio) of -0.05.

AXIS Latest News

Axis Reports Q4 2024 & 2024 Fiscal Year Financial Results

Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a financial technology company changing the way Canadians purchase and finance used vehicles, today announced financial results for...

Axis Provides Update on Strategic Review Process

TORONTO, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a financial technology company changing the way Canadians purchase and finance used...

Axis Reports Q3 2024 Financial Results & Updates on Strategic Review Process

Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a financial technology company changing the way Canadians purchase and finance used vehicles, today announced financial results for...

Axis Initiates a Strategic Review

Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a fintech lender changing the way Canadians finance used vehicles, announces that it has initiated a review of strategic alternatives...

Axis Reports Q2 2024 Financial Results

Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a financial technology company changing the way Canadians purchase and finance used vehicles, today announced financial results for...

Axis Announces Results of Director Election

Axis Auto Finance Inc. ("Axis" or the "Company") [TSX: AXIS] reports in accordance with the policies of the Toronto Stock Exchange, that the nominees listed in the management information circular...

Axis Reports Q1 2024 Financial Results

Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a rapidly growing financial technology company changing the way Canadians purchase and finance used vehicles, today announced...

Axis Reports Q4 and 2023 Fiscal Year Financial Results

Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a rapidly growing financial technology company changing the way Canadians purchase and finance used vehicles, today announced...

Axis Provides Business Update and Announces Closing of $2.67 Million Private Placement of Unsecured Subordinated Debentures

TORONTO, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Axis Auto Finance Inc. ("Axis" or the "Company") [TSX: AXIS], a financial technology company changing the way Canadians purchase and finance used...

Axis Reports Q3 Fiscal 2023 Financial Results

Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a rapidly growing financial technology company changing the way Canadians purchase and finance used vehicles, today announced...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.005-33.33333333330.0150.0150.01672640.01437559CS
4-0.005-33.33333333330.0150.0250.01649180.01288834CS
12-0.04-800.050.050.01346960.01715648CS
26-0.05-83.33333333330.060.070.01202360.02480952CS
52-0.105-91.30434782610.1150.1150.01206820.0482583CS
156-0.64-98.46153846150.650.730.01203760.30925639CS
260-0.64-98.46153846150.650.730.01203760.30925639CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
134AUPraise Inc
 0.00
(0.00%)
0
1332Nissui Corporation
 0.00
(0.00%)
0
132AIN Holdings Co Ltd
 0.00
(0.00%)
0
131ACCN Group Corp
 0.00
(0.00%)
0
130AVeritas In Silico Inc
 0.00
(0.00%)
0
134AUPraise Inc
 0.00
(0.00%)
0
1332Nissui Corporation
 0.00
(0.00%)
0
132AIN Holdings Co Ltd
 0.00
(0.00%)
0
131ACCN Group Corp
 0.00
(0.00%)
0
130AVeritas In Silico Inc
 0.00
(0.00%)
0
134AUPraise Inc
 0.00
(0.00%)
0
1332Nissui Corporation
 0.00
(0.00%)
0
132AIN Holdings Co Ltd
 0.00
(0.00%)
0
131ACCN Group Corp
 0.00
(0.00%)
0
130AVeritas In Silico Inc
 0.00
(0.00%)
0

Discussion

View Full Feed
Money hunt Money hunt 6 minutes ago
It can move violently with the right sugar and spice news, would be nice if their Ai technology really works
FOXO
Walter4 Walter4 7 minutes ago
Can't wait to see what the 2024 - 2025 results are. Will Jake and his scam make the list?


https://www.sec.gov/newsroom/press-releases/2023-234
BCAP
trunkmonk trunkmonk 7 minutes ago
Best thing for investors, and our financial system, is for the judge to deny the appeal. There is no precedence and setting one now is important. The weasel scab is just looking for more money to fight other crypto exchange cases.
XRPUSD
pepeoil pepeoil 8 minutes ago
I wonder if the receiver will pay the 3 stooges 6 figure bonuses?
SHMP
pepeoil pepeoil 9 minutes ago
The caddy probably cost 20 million
SHMP
chicks0123 chicks0123 9 minutes ago
Good morning CLNVers
CLNV
Money hunt Money hunt 11 minutes ago
FOXO Way undervalued at these levels,will bounce with some positive updates
FOXO
frans frans 14 minutes ago
MYNA 1.63 x 1.70 where we go ???
KXIN
mauismart mauismart 15 minutes ago
May have to buy more shares today. We continue to build momentum as we enter the 4th quarter with a great ceo.
AVXL
frans frans 16 minutes ago
MYNA 1.64 X1.70 up 30%
Diamondhands45 Diamondhands45 16 minutes ago
Why don’t you prove that troll baby. lol

Also remember a paleo diet and those girly boobs may go away
MDCE
Money hunt Money hunt 17 minutes ago
Start you engines100m market cap valuation Next resistance will be tested
RNAZ
Atown62 Atown62 19 minutes ago
I’m not the one who obsessively defended a Medicare man that commits fraud and plays dress up but that’s just me!
HHSE
MightyX MightyX 21 minutes ago
Putting together a large launch pad evidently.
TPTW
work-n-hard work-n-hard 21 minutes ago
In UMAC-LUXH-LGHL-MLGO
LGHL LUXH MLGO
MightyX MightyX 21 minutes ago
Says with certainty VuMe SuperApp will launch this year.
TPTW
sctts sctts 23 minutes ago
$$$ Today is the Day $$$$

$$$$ $frx $$$$
FRX
pottsville pottsville 23 minutes ago
I'm afraid Nuts he has a valid point 😆
SMME
dennisdave dennisdave 24 minutes ago
The company is worth $20billion right now in a normal market that was run by an honest exchange . Price is over $30 billion with only a MHRA approval and $75 billion with FDA approval.



good lord. You cant be serious. NWBO has zero revenue that does not change in the mo
NWBO
work-n-hard work-n-hard 24 minutes ago
MLGO: lol That candle is about 50% of the final price.
MLGO
Sltan Sltan 24 minutes ago
Think mergers and acquisitions

https://pitchbook.com/profiles/company/437230-27#overview
RNVA
arachnodude arachnodude 26 minutes ago
Wow! Denial is deep here. Easy to keep it going, though, when choosing to insert alternative realities. I'd suggest attempting to go beyond focusing on just the Risk Factors section of the filings. Maybe allow oneself to view the MANY excerpts I've provided straight from these legal filings over the
KBLB
tradernewstip tradernewstip 27 minutes ago
$AIMD #Nasdaq Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome https://finance.yahoo.com/news/ainos-spotlighted-water-tower-research-145500248.html
AIMD
StayHumble StayHumble 28 minutes ago
Power2 the P1ayers Huzzah!🟩24/7 interest here🟩 🟩
GME
Just the facts maam Just the facts maam 29 minutes ago
Further evidence that ANIP is preparing to be bought out. On July 29. 2024, Novitium Pharma (ANIP subsidiary) gained NDA approval for Tezruly (oral solution of terazosin) and was authorized to market it August 1, 2024. ANIP never announced the approval or launched the drug. According to the Orange
ANIP

Your Recent History

Delayed Upgrade Clock